Drawing for LYOCELL

USPTO serial 76373277

LYOCELL

Reviewed by CopyMark Law Group

Reg. 2824420Status 710
Filing date
Status date
Registration date
Mar 23, 2004
Examiner
CASE, LEIGH CAROLINE
Law office
TMEG LAW OFFICE 105

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with LYOCELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations consisting of nano and micro particles that contain bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics, and anti-inflammatory agents, veterinary preparations consisting of nano and micro particles containing bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics and anti-inflammatory agentsSECTION 8 - CANCELLEDApr 30, 2000

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2014CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
May 14, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 31, 2010C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 31, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 19, 2010E815TEAS SECTION 8 & 15 RECEIVED—
Mar 23, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 30, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 10, 2003NPUBNOTICE OF PUBLICATION—
Sep 15, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 27, 2003CFITCASE FILE IN TICRS—
Aug 21, 2003MAILPAPER RECEIVED—
Aug 20, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 20, 2003MAILPAPER RECEIVED—
Aug 19, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 19, 2003FAXXFAX RECEIVED—
Feb 20, 2003UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Feb 20, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 17, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 17, 2002MAILPAPER RECEIVED—
Oct 18, 2002DOCKASSIGNED TO EXAMINER—
Jun 27, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance